Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing

Nature Medicine

Volumn 5, Issue 12, 1999, Pages 1418-1423

  Jones, Michael K ^a   Wang, Hongtao ^b   Peskar, Brigitta M ^c   Levin, Ellis ^a,b   Itani, Rabiha M ^a   Sarfeh, I James ^a,b   Tarnawski, Andrzej S ^a,b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; IBUPROFEN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANGIOGENESIS; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; COLON CANCER; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; GASTRODUODENAL ULCER; NONHUMAN; PRIORITY JOURNAL; RAT; SOLID TUMOR; WOUND HEALING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; ENDOTHELIUM, VASCULAR; FLAVONOIDS; HUMANS; INDOMETHACIN; ISOENZYMES; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NITROBENZENES; PEPTIC ULCER; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; SULFONAMIDES; WOUND HEALING;

EID: 0032750920     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/70995     Document Type: Article

References (25)

1. Folkman, J. & Shing, Y. Angiogenesis. J. Biol. Chem. 267, 10931-10934 (1992).
2. Tarnawski, A. et al. in Mechanisms of Peptic Ulcer Healing/Falk Symposium 59. (eds. Halter, F., Garner, A. & Tytgat, G.N.J.) 165-171 (Kluwer Academic, London, 1991).
3. Schuna, A.A. Update on treatment of rheumatoid arthritis. J. Am. Pharm. Assoc. (Wash.) 38, 728-735 (1998).
4. Goodnight, S.H. Aspirin therapy for cardiovascular disease. Curr. Opin. Hematol. 3, 355-360 (1996).
5. Sheng, H. et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest. 99, 2254-2259 (1997).
6. Shift, S.J. & Rigas, B. Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions. Gastroenterology 113, 1992-1998 (1997).
7. Sloane, P.D. Advances in treatment of Alzheimer's disease. Am Fam. Physician 58, 1577-1586 (1998).
8. Fries, J.F. NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal. J. Rheumatol. 18, 6-10 (1991).
9. Shea-Donohue, T., Steel, L., Montcalm-Mazzilli, E. & Dubois, A. Aspirin-induced changes in gastric function: role of endogenous prostaglandins and mucosal damage. Gastroenterology 98, 284-292 (1990).
10. Smith, W. & Marnett, L. Prostaglandin endoperoxide synthase: structure and catalysis. Biochem. Biophys. Acta. 1083, 1-17 (1991).
11. DeWitt, D.L., Meade, E.A. & Smith, W.L. PGH synthase isoenzyme selectivity: the potential for safer non-steroidal drugs. Am. J. Med. 95, 40S-44S (1993).
12. Florkiewicz, R.Z. & Sommer, A. Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons. Proc. Natl. Acad. Sci. USA 86, 3978-3981 (1989).
13. Nicosia, R.F., Lin, Y.J., Hazelton, D. & Qian, X. Endogenous regulation of angiogenesis in the rat aorta model: role of vascular endothelial growth factor. Am. J. Pathol. 151, 1379-1386 (1997).
14. Jones, M.K., Sarfeh, I.J. & Tarnawski, A.S. Induction of in vitro angiogenesis in the endothelial-derived cell line EA hy926, by ethanol is mediated through PKC and MAPK. Biochem. Biophys. Res. Comm. 249, 118-123 (1998).
15. Tsujii, M. et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93, 705-716 (1998).
16. Skopinska-Rozewska, E. et al. Inhibition of angiogenesis by sulindac and its sulfone metabolite (FGN-1): a potential mechanism for their antineoplastic properties. Int. J. Tissue React. 20, 85-89 (1998).
17. Futaki, N. et al. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47, 55-59 (1994).
18. Masferrer, J.L. et al. Selective inhibition of inducible cyclooxygenase 2 in vitro is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA 91, 3228-3232 (1994).
19. McCarthy, D.M. Mechanisms of mucosal injury and healing: the role of non-steroidal-anti-inflammatory drugs. Scand. J. Gastroenterol. 208, 9-16 (1995).
20. Tarnawski, A. et al. Angiogenic response of gastric mucosa to ethanol injury is abolished by indomethacin. Gastroenterology 96, A505 (1989).
21. Tarnawski, A. et al. in Mechanism of Injury, Protection and Repair of the Upper Gastrointestinal Tract (eds. Garner, A., & O'Brien, P.E.) 521-531 (J. Willey & Sons, Chichester, 1991).
22. Schmassmann, A. et al. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Br. J. Pharmacol. 123, 795-804 (1998).
23. Scharschmidt, L.A. & Dunn, M.J. Prostaglandin synthesis by rat glomerular mesangial cells in culture. Effects of angiotensin II and arginine vasopressin. J. Clin. Invest. 71, 1756-1764 (1983).
24. Pai, R., Ohta, M., Itani, R.M., Sarfeh, I.J. & Tarnawski, A.S. Induction of mitogen-activated protein kinase signal transduction pathway during gastric ulcer healing in rats. Gastroenterology 114, 706-713 (1998).
25. Peskar, B.A., Steffens, C. & Peskar, B.M. in Radioimmunoassay of Drugs and Hormones in Cardiovascular Medicine (eds Albertini, A., DaPrada, M. & Peskar, B.A.) 239-250 (Elsevier/North Holland Biomedical, Amsterdam, New York, Oxford, 1979).